Literature DB >> 17243784

A TAD further: exogenous control of gene activation.

Anna K Mapp1, Aseem Z Ansari.   

Abstract

Designer molecules that can be used to impose exogenous control on gene transcription, artificial transcription factors (ATFs), are highly desirable as mechanistic probes of gene regulation, as potential therapeutic agents, and as components of cell-based devices. Recently, several advances have been made in the design of ATFs that activate gene transcription (activator ATFs), including reports of small-molecule-based systems and ATFs that exhibit potent activity. However, the many open mechanistic questions about transcriptional activators, in particular, the structure and function of the transcriptional activation domain (TAD), have hindered rapid development of synthetic ATFs. A compelling need thus exists for chemical tools and insights toward a more detailed portrait of the dynamic process of gene activation.

Mesh:

Substances:

Year:  2007        PMID: 17243784     DOI: 10.1021/cb600463w

Source DB:  PubMed          Journal:  ACS Chem Biol        ISSN: 1554-8929            Impact factor:   5.100


  36 in total

1.  The contribution of transactivation subdomains 1 and 2 to p53-induced gene expression is heterogeneous but not subdomain-specific.

Authors:  Jennifer M Smith; Lawton J Stubbert; Jeffrey D Hamill; Bruce C McKay
Journal:  Neoplasia       Date:  2007-12       Impact factor: 5.715

2.  Inhibition of high-mobility-group A2 protein binding to DNA by netropsin: a biosensor-surface plasmon resonance assay.

Authors:  Yi Miao; Tengjiao Cui; Fenfei Leng; W David Wilson
Journal:  Anal Biochem       Date:  2007-10-23       Impact factor: 3.365

3.  Chemical biology: A Notch above other inhibitors.

Authors:  Paramjit S Arora; Aseem Z Ansari
Journal:  Nature       Date:  2009-11-12       Impact factor: 49.962

4.  Transient-state kinetic analysis of transcriptional activator·DNA complexes interacting with a key coactivator.

Authors:  Amberlyn M Wands; Ningkun Wang; Jenifer K Lum; John Hsieh; Carol A Fierke; Anna K Mapp
Journal:  J Biol Chem       Date:  2011-02-12       Impact factor: 5.157

Review 5.  Transcriptional switches: chemical approaches to gene regulation.

Authors:  Lori W Lee; Anna K Mapp
Journal:  J Biol Chem       Date:  2010-02-10       Impact factor: 5.157

6.  Synergistic enhancement of the potency and selectivity of small molecule transcriptional inhibitors.

Authors:  Christopher E Taylor; Quintin Pan; Anna K Mapp
Journal:  ACS Med Chem Lett       Date:  2012-01-12       Impact factor: 4.345

7.  Inhibition of ErbB2(Her2) expression with small molecule transcription factor mimics.

Authors:  Lori W Lee; Christopher E C Taylor; Jean-Paul Desaulniers; Manchao Zhang; Jonas W Højfeldt; Quintin Pan; Anna K Mapp
Journal:  Bioorg Med Chem Lett       Date:  2009-09-01       Impact factor: 2.823

Review 8.  Riboactivators: transcription activation by noncoding RNA.

Authors:  Aseem Z Ansari
Journal:  Crit Rev Biochem Mol Biol       Date:  2009 Jan-Feb       Impact factor: 8.250

9.  Tra1 as a screening target for transcriptional activation domain discovery.

Authors:  Chinmay Y Majmudar; Anne E Labut; Anna K Mapp
Journal:  Bioorg Med Chem Lett       Date:  2009-05-18       Impact factor: 2.823

10.  Impact of nonnatural amino acid mutagenesis on the in vivo function and binding modes of a transcriptional activator.

Authors:  Chinmay Y Majmudar; Lori W Lee; Jody K Lancia; Adaora Nwokoye; Qian Wang; Amberlyn M Wands; Lei Wang; Anna K Mapp
Journal:  J Am Chem Soc       Date:  2009-10-14       Impact factor: 15.419

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.